Minors aged 12 to 17 years old who received the first dose of the coronavirus disease (COVID-19) vaccine have reached more than 9,000.
According to the Muntinlupa City government, as of Nov. 11, a total of 9,301 minors with and without comorbidities were vaccinated in Muntinlupa.
The total is equivalent to 17 percent of the estimated 55,391 population of 12 to 17 years old in Muntinlupa, rising from 5,648 vaccinated minors (10.2 percent of the total) recorded last Nov. 8.
The number of minors who have registered with the Muntinlupa City COVID-19 Vaccination Program (MunCoVac) also rose to 26,235 as of Nov. 11, or 47 percent of the total population of 12 to 17-year-olds, from 22,665 minors registered last Nov. 8, or 41 percent.
Of the 26,235 minor registrants, 2,117 (8.1 percent) have comorbidities, classified by the Department of Health (DOH) under Pediatric A3 group while 24,102 (91.9 percent) are “well children,” or those with no comorbidities.
According to MunCoVac, for minors without comorbidities, parents or guardians need to present a valid ID of the child, valid ID and proof of residency of the parent/guardian, proof of filiation such as birth certificate and vaccination card of the parent/guardian (if they are already vaccinated).
For minors with comorbidities, parents or guardians need to present a DOH medical certificate of the child, valid IDs of the child and parent/guardian, proof of filiation such as birth certificate and vaccination card of the parent/guardian (if they are already vaccinated).
Minors with comorbidities are vaccinated only at the city-run Ospital ng Muntinlupa. For “well children,” the vaccination sites in Muntinlupa are SM Center Muntinlupa, Ayala Malls South Park, New Cupang Health Center and Sucat covered court.
According to the DOH, comorbidities eligible for the Pediatric A3 vaccination are medical complexity, genetic conditions, neurologic conditions, metabolic/endocrine diseases, cardiovascular diseases, obesity, HIV infection, tuberculosis, chronic respiratory diseases, renal disorders, hepatobiliary diseases and immunocompromised state due to disease or treatment.
The two vaccines approved for use in people 12 years old and above in the country are Pfizer-BioNTech and Moderna.